Acne treated successfully with azithromycin

Kapadia, Naseema; Talib, Abu

doi:10.1111/j.1365-4632.2004.02058.x

Cited by 31 publications

(22 citation statements)

References 5 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…At the end of 12 weeks treatment 87% improvement observed in term of percent reduction of MichaelssonAcne Severity Index. These findings are more superiortothose observed in different studies by using azithromycin 4,5,7 and topicaladapalene 3,1011,12,13 alone.…”

Section: Discussionsupporting

confidence: 61%

“…Therefore they failed to gain acceptance. In many Western journals, the efficacy and safety of azithromycin in treatment of acne have been reviewed and articles on clinical trials published 4,5,6,7 .…”

Section: Discussionmentioning

confidence: 99%

“…Azithromycin is approved mainly for the treatment of uncomplicated upper respiratory tract and skin infection, gonococcal and genital chlamydial infection but it appears to have a broad spectrum of activity with enhanced activity in vitro against P.acnes. The efficacy and safety of azithromycin therapy in acne vulgaris has been reviewed in many Western journals [4][5][6][7] and articles on clinical trials has been published. The effect of azithromycin 3 days oral dose lasts for 10 days, which gave rationale to use as pulse therapy.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Oral Azithromycin Pulse Therapy and Daily Topical Adapalene in the Treatment of Acne Vulgaris: An Open Randomized Noncomparative Study

et al. 2017

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 61%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Oral Azithromycin Pulse Therapy and Daily Topical Adapalene in the Treatment of Acne Vulgaris: An Open Randomized Noncomparative Study

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Duyarlı mikroorganizmaların 50S ribozomal subunitine bağlanarak protein sentezini engeller 11,12 . Azitromisin farklı çalışmalarda farklı şekillerde [13][14][15] kullanılmış olmakla birlikte en sık görülen uygulama şekli haftada 3 kez 500 mg dozunda kullanımıdır [16][17][18] . Kapadia ve ark.…”

Section: Discussionunclassified

“…Kapadia ve ark. 17 inflamatuvar aknesi olan 35 hasta ile yaptıkları çalışmada, 12 hafta boyunca %0,5 tretinoin ile birlikte azitromisini haftada 3 kez 500 mg dozunda uygulamışlar, çalışmanın sonunda inflamatuvar akne lezyonlarında %80'e yakın düzelme saptamışlardır. Innocenzi ve ark.…”

Section: Discussionunclassified

Akne Vulgaris Tedavisinde Oral Azitromisin ile Topikal Adapalen ve Oral Doksisiklin ile Topikal Adapalen Etkinliğinin ve Güvenirliğinin Karşılaştırılması ve bu Tedavilerin Yaşam Kalitesi Üzerine Etkilerinin Ölçülmesi

...

2012

Turkderm

View full text Add to dashboard Cite

Sum maryBackground and Design: Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit. Oral antibiotics and topical retinoids are effective in the treatment of acne. Materials and Methods: In this study, 60 patients with moderate acne vulgaris were evaluated; the patients were randomized into two equal groups. The groups were matched with respect to age, gender and clinical severity of acne. The patients in group 1 received oral azithromycin (500 mg daily on 3 consecutive days per week) and the patients in group 2 received doxycycline (100 mg daily) for 12 weeks. Topical adapalene gel was added to the systemic treatment in both groups. Clinical evaluation was performed at baseline and at the end of first, second and third months. Side effects were recorded. Quality of life in patients was measured with Skindex-29 and Acne Quality of Life Scale before treatment and at the end of third month.

show abstract

Adverse Effects of Acne Medications: Recognition and Management

et al. 2015

View full text Add to dashboard Cite

Acne vulgaris is a very common chronic inflammatory disease of the skin. The clinical features of acne range from non-inflammatory comedones to inflammatory nodules. While often perceived as an adolescent disease, the prevalence remains high into adulthood, and the manifestations can have detrimental psychosocial effects. It is therefore not surprising that many patients are motivated to seek treatment. The existing treatment strategies for acne are complex due to the multifactorial pathogenesis of the disease. Although it is difficult to cure, four categories of medications have proved efficacious in reducing acne lesions: topical agents, systemic antibiotics, systemic retinoids, and hormonal agents. Unfortunately, these medications can cause adverse effects that may limit their use. Typically, these adverse effects are mild and transient and can be remedied by altering the dose or frequency of the offending agent. However, more serious adverse effects can occur that pose a significant health risk to the patient. Understanding how to recognize and manage the adverse effects of common acne therapies is imperative to providing the safest and most appropriate treatment for each patient. This article focuses on the recognition and management of adverse effects associated with current acne medications.

show abstract

Acne treated successfully with azithromycin

Abstract: Azithromycin, 500 mg thrice weekly for 12 weeks, is a safe and effective treatment of acne vulgaris with excellent patient compliance.

Cited by 31 publications

References 5 publications

Oral Azithromycin Pulse Therapy and Daily Topical Adapalene in the Treatment of Acne Vulgaris: An Open Randomized Noncomparative Study

Oral Azithromycin Pulse Therapy and Daily Topical Adapalene in the Treatment of Acne Vulgaris: An Open Randomized Noncomparative Study

Akne Vulgaris Tedavisinde Oral Azitromisin ile Topikal Adapalen ve Oral Doksisiklin ile Topikal Adapalen Etkinliğinin ve Güvenirliğinin Karşılaştırılması ve bu Tedavilerin Yaşam Kalitesi Üzerine Etkilerinin Ölçülmesi

Adverse Effects of Acne Medications: Recognition and Management

Contact Info

Product

Resources

About